“Active surveillance: protecting patients from harm”

If you want to get a current update on the management of patients on active surveillance, you need to listed to/watch this presentation by Dr. Lawrence Klotz on the UroToday web site. But you will need 45 minutes. … READ MORE …

Published data on Klotz’s active surveillance series at c. 20 years

In a report published on line on Monday, in the Journal of Clinical Oncology, Klotz et al. have now provided peer-reviewed data from their nearly 20-year-long series of patients managed on active surveillance. … READ MORE …

Klotz, Epstein criteria for active surveillance and actual surgical outcomes

There is no broad agreement agreement (yet) across the prostate cancer community about acceptable “standard” criteria for eligibility for active surveillance as a form of first-line management of low-risk prostate cancer. On the other hand, there are two well-characterized and relatively broadly applied sets of criteria: … READ MORE …